ACMI - Accumed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sigmund who wrote (1513)	3/10/1998 10:39:00 AM
From: Frank Buck	Read Replies (1) of 1894

Sigmund, Your last post mentions SKB; <And that quarter may not be decisive in that SKB may convert to primary screening as a sign of support for NeoPath even if it costs them money. In that case, NeoPath may not be unmasked before Nov. Who is SKB and why would they be in allegiance with the primary screening technology of NPTH if it costs them additional uncompensable monies for HPV screening? What do you think of the statement by AccuMed (last release): <In a related matter, the Board voted not to complete the equity carve-out of the research and development portion of its cytopathology business as previously announced. The Company has engaged an investment banker to pursue other financing alternatives. Lavallee explained, "We will continue discussions with our intended equity partners, as well as seek other strategic relationships." It sounds as though AccuMed is going to attempt to take their present portion (66%) of Oncometrics (Savant) public. Perhaps this will fill the coffers for a while until they can become profitable. Thanks Frank

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next